- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01742247
Assessment of Needs of Moisturizers After Various Laser Treatments
March 29, 2016 updated by: Pusan National University Hospital
Phase 4 Study of Assessment of Needs of Moisturizers After Various Laser Treatment
Assessment of needs of moisturizers after various laser treatments
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators would like to assess of needs of moisturizers after various laser treatment
: by investigating the changes in the skin barrier function after fractional carbon dioxide laser and fractional Er:Glass laser in mice and human skin
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Busan, Korea, Republic of
- Department of dermatology, Pusan National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- at least 18 years of age without any dermatologic diseases
Exclusion Criteria:
- Taking other known dermatologic disease
- Others who are shown pigmented lesion on treated-area
- Who have allergy or history of hypersensitivity reaction to moisturizers
- Who have other definitive cutaneous findings
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Physiogel, Laser therapy, Moisturizer
Experimental: Physiogel treated & Non-treated 1 Palmitoylethanolamide, Physiogel 3 times a day for 2 weeks |
Application of moisturizer on laser-treated area
Other Names:
Application of moisturizer on laser-treated area
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical assessment of erythema, transepidermal water loss
Time Frame: 2weeks
|
The clinical assessment of erythema, pigmentation, transepidermal water loss will be evaluated by using apparatus.
|
2weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Byung-Soo Kim, Ph.D., Pusna National University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
April 1, 2015
Study Completion (Actual)
December 1, 2015
Study Registration Dates
First Submitted
December 3, 2012
First Submitted That Met QC Criteria
December 4, 2012
First Posted (Estimate)
December 5, 2012
Study Record Updates
Last Update Posted (Estimate)
March 30, 2016
Last Update Submitted That Met QC Criteria
March 29, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Skin Diseases
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Peripheral Nervous System Agents
- Antiviral Agents
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Cannabinoid Receptor Agonists
- Cannabinoid Receptor Modulators
- Palmidrol
Other Study ID Numbers
- PNUHDM-laser and moisturizers
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dermatologic Disorders
-
Northwestern UniversityCompletedDermatologic DisordersUnited States
-
Medical University of GrazJoanneum Research Forschungsgesellschaft mbHCompleted
-
Sohag UniversityNot yet recruitingDermatologic Disorders With Heamatologic Malignancies PatientsEgypt
-
University of ViennaMedical University of ViennaCompletedDermatologic Disorders | Disorder of Cholesterol Metabolism
-
Stemedica Cell Technologies, Inc.Active, not recruitingDermatologic Disorders | Chronic Effect of Ultraviolet Radiation on Photoaged SkinUnited States
-
University of California, IrvineBeckman Laser Institute University of California IrvineRecruitingDermatologic DiseasesUnited States
-
DermTechRecruitingDermatologic DiseasesUnited States
-
University Hospital, Basel, SwitzerlandCompleted
-
University of ZurichCompletedDermatologic Disease of Inpatients in Internal MedicineSwitzerland
Clinical Trials on Physiogel
-
University Hospital MuensterCompleted
-
GlaxoSmithKlineCompleted
-
Eun-ji KimCompletedSkin LesionKorea, Republic of
-
University of ZurichCompleted
-
GlaxoSmithKlineCompletedSunscreening AgentsGermany